Very interesting and good update considering the investor show in the US - after Asian in March in I am correct - just before two major strategic Ann releases in the next 1 to 2 weeks and I personally consider it very positive as the company already has the missing antiviral data but double checking and finalising prior to un-blinding. He would not go to the US - possibly looking for more money for Phase 3 trial financing - unless be very confident of the results.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.67M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 17.0¢ | $107.4K | 601.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 58773 | 1 |
View Market Depth
| Last trade - 15.55pm 13/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |